Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 4 1Phase 2 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2CNS 1Breast 1

Conditions

Liver Neoplasms 1Fibrosis 1Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 309Oxaliplatin 260Leucovorin 234Capecitabine 198Irinotecan 147Gemcitabine 128Cisplatin 126Bevacizumab 119Radiotherapy 72Paclitaxel 64Folfox protocol 56Cetuximab 56Drug Therapy 46Sorafenib 45Docetaxel 42S 1 (combination) 40Chemotherapy, Adjuvant 38Neoadjuvant Therapy 37pembrolizumab 36130-nm albumin-bound paclitaxel 28Surgical Procedures, Operative 27regorafenib 25lenvatinib 24XELOX 24Panitumumab 24Radiation 23Nivolumab 23atezolizumab 22Carboplatin 22trifluridine tipiracil drug combination 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × contrast agent BR1 × Gastrointestinal × Clear all
NCT04006275 2019-09-19

Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCC

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 3 Unknown
100 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT00829413 2018-08-03

SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization

Bracco Diagnostics, Inc

Phase 3 Completed
353 enrolled 16 charts
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡